Pulsed Radiofrequency in Postherpetic Neuralgia: Predictors of Treatment Response from a Doubly Robust Propensity-Weighted Real-World Study
Pain Medicine · 14.11.2026
DOI: 10.1093/pm/pnag116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Medicine, online erschienen am 14.11.2026. Verfasst von Hangaram Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea.
Abstract (Originalsprache)
Background
Postherpetic neuralgia (PHN) is a debilitating complication of herpes zoster. Evidence supporting pulsed radiofrequency (PRF) in established chronic PHN remains limited, with inadequate adjustment for baseline confounders. We evaluated the association between PRF and treatment success and identified predictors of treatment response.
Methods
In this retrospective cohort study, 982 patients with PHN (pain persisting ≥ 12 weeks after rash onset) were analyzed. Patients who underwent PRF (n = 504)—targeting the dorsal root ganglion, the Gasserian ganglion, or involved peripheral nerves—were compared with controls who did not undergo PRF at any time during the study period and who received standard pharmacological and non-PRF interventional management (n = 478). Propensity score-based overlap weighting (ATO) balanced 29 baseline covariates. The primary outcome was treatment success at 12 weeks (≥ 2-point reduction on the 11-point numeric rating scale (NRS)). Effects were estimated using doubly robust estimation.
Results
After ATO adjustment, all covariates achieved adequate balance (standardized mean differences < 0.1). Treatment success at 12 weeks was 63.0% (PRF) versus 52.1% (control; doubly robust OR, 1.59; 95% CI, 1.12–2.25; P = .009). Greater mean pain reduction was observed at 4 weeks (P = .040) but not sustained thereafter. Exploratory subgroup analyses suggested PRF was more effective in patients with dysesthesia, without allodynia, and not receiving pregabalin or tramadol.
Conclusions
PRF provides clinically meaningful, albeit time-limited, pain reduction in PHN patients. Exploratory findings suggest that treatment response may vary according to sensory phenotype and pharmacological profile, underscoring the importance of profile-guided patient selection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea.
- Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Jee Youn Moon
Zitieren
APA
Kim, H., Park, E. B., Park, B., Nam, S., Lee, K., Yu, S., Kim, J., Yoo, Y., & Moon, J. Y. (2026). Pulsed Radiofrequency in Postherpetic Neuralgia: Predictors of Treatment Response from a Doubly Robust Propensity-Weighted Real-World Study. Pain Medicine. https://doi.org/10.1093/pm/pnag116
Vancouver
Kim H, Park EB, Park B, Nam S, Lee K, Yu S, et al. Pulsed Radiofrequency in Postherpetic Neuralgia: Predictors of Treatment Response from a Doubly Robust Propensity-Weighted Real-World Study. Pain Medicine. 2026. doi:10.1093/pm/pnag116
BibTeX
@article{Kim2026,
author = {Kim, Hangaram and Park, Eun Bi and Park, Beomil and Nam, Seungpyo and Lee, Kaehong and Yu, Seungcheol and Kim, Jeongsoo and Yoo, Yongjae and Moon, Jee Youn},
title = {Pulsed Radiofrequency in Postherpetic Neuralgia: Predictors of Treatment Response from a Doubly Robust Propensity-Weighted Real-World Study},
journal = {Pain Medicine},
year = {2026},
doi = {10.1093/pm/pnag116}
}
EUVIMED